A Case Report of Successful Treatment with Dose-controlled mFOFOX6+Bevacizumab for Metastatic Colorectal Cancer in Patient Receiving Hemodialysis-Reference-Cited by-同舟云学术

A Case Report of Successful Treatment with Dose-controlled mFOFOX6+Bevacizumab for Metastatic Colorectal Cancer in Patient Receiving Hemodialysis

Published:2024-08-01 Issue:8 Volume:144 Page:847-852
ISSN:0031-6903
Container-title:YAKUGAKU ZASSHI
language:en
Short-container-title:YAKUGAKU ZASSHI

Author:

Ozeki Ayumi¹²,Kokubun Hideya¹,Ibuki Sho³,Inamoto Masayuki²,Sakurai Yoshihiko³,Otani Takahiro²,Sato Junya¹

Affiliation:

1. Shonan University of Medical Sciences

2. Department of Pharmacy, Shonan General Hospital

3. Department of Surgery, Shonan General Hospital

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/yakushi/144/8/144_24-00004/_pdf

Reference21 articles.

1. 1) Foundation for Promotion of Cancer Research. “Cancer Statistics in Japan 2023.”: 〈https://ganjoho.jp/public/qa_links/report/statistics/2023_jp.html〉, cited 8 November, 2023.

2. 2) Center for Cancer Control and Information Services, National Cancer Center. “Monitoring of cancer Incidence in Japan-Survival 2009–2011 Report.”: 〈https://ganjoho.jp/public/qa_links/report/ncr/pdf/mcij2009-2011_report.pdf〉, cited 8 November, (2023).

3. 3) Hanafusa N., Abe M., Jyoki N., Hoshino J., Wada A., Kikuchi K., Goto S., Ogawa T., Kanda E., Taniguchi M., Nakai S., Naganuma T., Hasegawa T., Miura K., Takemoto Y., J. Jpn. Soc. Dial. Ther., 55, 665–723 (2022).

4. 4) United States Renal Data System. “2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020” 〈https://usrds-adr.niddk.nih.gov/2020/end-stage-renal-disease/11-international-comparisons〉, cited 8 November, (2023).

5. 5) Kaizu K., Tanaka Y., Tokui N., Shindan to Chiryou, 101, 1071–1076 (2013).